À retenir
In 31 older adults doing two two-minute walk tests, the Fitbit Flex and ChargeHR agreed well with directly observed steps (ICC 0.86, 95% CI 0.76-0.93), but both underestimated step counts. The sample was small and the home comparison used another device as the yardstick, so it supports consistency more than exact accuracy.
Study design
Validation : étude/revue
Reading basis
Published abstract
Reading focus
Reference & error
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Many older adults are sedentary, and fitness trackers might help them move more, but older people walk differently and trackers may not count their steps correctly. The authors tested the reliability and validity of two Fitbit models for step counts in older adults, in a laboratory and at home.
Population et méthode
Validation study. Participants completed two two-minute walk tests (2MWT) while wearing the fitness trackers (Fitbit Flex and ChargeHR) and were videoed to count steps directly. They then wore one tracker and a GENEactiv accelerometer at home for 14 days. Thirty-one participants completed both 2MWTs and 30 completed the free-living part. Agreement was measured with intraclass correlation (ICC) and Spearman correlations. The abstract does not report participants' ages or the size of the undercount.
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Against directly observed steps, the trackers' criterion validity was high (ICC 0.86, 95% CI 0.76-0.93), but both devices underestimated steps.
- 2Test-retest reliability between the two walk tests was excellent (ICC of at least 0.75) for each device, particularly the ChargeHR.
- 3At home, the tracker's total distance and steps agreed well with moderate-to-vigorous activity from the GENEactiv (Spearman rho 0.78 and 0.74).
Limites et incertitude
- 1Only 31 people did the lab tests and 30 the home period, so the estimates are imprecise and not for all older adults.
- 2A two-minute walk is short and does not cover daily movements such as slow shuffling or household tasks.
- 3At home, the Flex and ChargeHR were compared with an accelerometer, which is another estimate rather than true steps.
- 4This reading is based on the abstract only.
Mise en perspective
These trackers appear consistent for older adults and track steps in relative terms, but they count fewer steps than actually taken in the lab. Use them to see whether you are doing more or less over time rather than to hit an exact number.
Vos données
Use the same tracker on the same wrist, and compare weekly step trends. Because these models tended to undercount in the lab, your absolute number may be lower than reality, but changes over time are still meaningful.
Comprendre ce type de preuve
Agreement is specific to the device, firmware, reference, population and setting. Correlation is not agreement, and validating a metric is not proof of diagnostic or treatment benefit.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Background
Two-thirds of older Australians are sedentary. Fitness trackers have been popular with younger people and may encourage older adults to become more active. Older adults may have different gait patterns and as such it is important to establish whether fitness trackers are valid and reliable for this population. The aim of the study was to test the reliability and validity of two fitness trackers (Fitbit Flex and ChargeHR) by step count when worn by older adults. Reliability and validity were tested in two conditions: 1) in the laboratory using a two-minute-walk-test (2MWT) and 2) in a free-living environment.
Methods
Two 2MWTs were completed while wearing the fitness trackers. Participants were videoed during each test. Participants were then given one fitness tracker and a GENEactiv accelerometer to wear at home for 14-days.
Results
Thirty-one participants completed two 2MWTs and 30 completed the free-living procedure. Intra Class Correlation's of the fitness trackers with direct observation of steps (criterion validity) was high (ICC:0.86,95%CI:0.76,0.93). However, both fitness trackers underestimated steps. Excellent test-retest reliability (ICC ≥ 0.75) was found between the two 2MWTs for each device, particularly the ChargeHR devices. Good strength of agreement was found for total distance and steps (fitness tracker) and moderate-to-vigorous physical activity (GENEactiv) for the free-living environment (Spearman Rho's 0.78 and 0.74 respectively).
Conclusion
Reliability and validity of the Flex and ChargeHR when worn by older adults is good, however both devices underestimated step count within the laboratory environment. These fitness trackers appear suitable for consumer use and promoting physical activity for older adults.
Sources et attribution
Reliability and validity of two fitness tracker devices in the laboratory and home environment for older community-dwelling people.
Burton E, Hill KD, Lautenschlager NT, Thøgersen-Ntoumani C, Lewin G, Boyle E, Howie E.
BMC geriatrics · 2018-05-03
DOI: 10.1186/s12877-018-0793-4 ↗PubMed · 29724191 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
Activity–stroke and heart attack curves differ by accelerometer processing method
Among 90,237 UK Biobank adults free of cardiovascular disease at baseline, followed until December 2022 for 1,298 strokes and 2,031 myocardial infarctions, the shape of the link between moderate-vigorous physical activity (MVPA) and each outcome depended on how the accelerometer data were processed. For stroke, hazard fell in a straight line only with the machine-learning metric; for myocardial infarction, two metrics gave a curved decline and activity counts a straight one. The abstract gives no hazard ratios, so it shows that methods disagree, not which one is right, and the findings are observational associations.
Preventive Medicine
Smartwatch data as forensic evidence: heart rate is best validated, the rest uneven
A systematic review and meta-analysis of studies on smartwatches from four major brands, framed around digital forensics, found that heart rate was both the most studied and the most accurate measure. Step count, distance, energy expenditure, activity classification and sleep were less consistently validated, and results varied by brand, protocol and reporting. The abstract gives no pooled numbers, and most studies were run in healthy people in laboratories, so it cannot say how a particular watch performs for a particular person in daily life.
Forensic Science International
Activity trackers: about 1,800 more steps a day, but small effects on other outcomes
An umbrella review of 39 systematic reviews and meta-analyses, covering 163,992 participants, found that activity trackers were associated with more physical activity (SMD 0.3–0.6), equating to about 1,800 extra steps and 40 minutes more walking per day, and with a bodyweight reduction of about 1 kg. Effects on blood pressure, cholesterol, glycosylated haemoglobin, quality of life and pain were typically small and often non-significant. The abstract does not say what else came with the trackers in these programs or how much the reviews overlap, so the gains cannot be credited to the device alone.
The Lancet Digital Health
Seven sleep trackers: good at spotting sleep, weak on wake and sleep stages
In a sleep laboratory, 34 healthy young adults wore a subset of seven consumer sleep trackers for three nights. Against polysomnography every device detected sleep very well (sensitivity 0.93 or higher) but caught wake poorly (specificity 0.18–0.54), and five of the seven matched or beat research actigraphy (specificity 0.39). Sleep-stage estimates were inconsistent, and the participants were healthy adults aged 18 to 35 in a fixed 8-hour bed window, with each device tested in only 11 to 20 of them, so the results say little about people with sleep problems.
Sleep

